CCN2 and Emery-Dreifuss muscular dystrophy 2, autosomal dominant: Previous studies showed increased levels of TGFbeta 2 in EDMD2 patient serum and the activation of profibrotic pathways mediated by TGFbeta 2 and CTGF in preclinical models of the disease [9,10].